Recent News About Besins Healthcare
View More
-
A federal judge has denied a Belgian drug maker’s attempt to remove itself from a massive class-action lawsuit that claims testosterone replacement drugs caused harm to patients taking them for off-label conditions.
-
A federal judge has declined to drop the Belgian company which makes Androgel and its American licensee from a multi-state class action lawsuit, which alleges the companies’ testosterone restorative drug is not only useless, but harmful. However, the judge did leave the door open that jurisdiction over the case could lay elsewhere.
-
The widow of a man who used a popular testosterone-replacement drug is suing the makers, alleging her husband was killed by the drug.
-
Joins growing list of plaintiffs suing AbbVie over AndroGel
